Market

Truist Securities lowers Arcus Biosciences stock price target on trial failure

Truist Securities lowers Arcus Biosciences stock price target on trial failure
Read More

Related Posts

Lululemon’s ousting of CEO draws praise from activist founder Chip Wilson

Lululemon’s ousting of CEO draws praise from activist f...

Wall St slides as inflation worries, AI bubble fears spook investors

Wall St slides as inflation worries, AI bubble fears sp...

Why Alphabet and Amazon could be two of the best AI stocks next year

Why Alphabet and Amazon could be two of the best AI sto...

Americans skeptical of Trump on Epstein, but Republican doubts ease, Reuters/Ipsos poll finds

Americans skeptical of Trump on Epstein, but Republican...

Guidewire stock price target raised to $300 by Citizens on cloud transition

Guidewire stock price target raised to $300 by Citizens...

Form 144 CNB FINANCIAL CORP/PA For: 12 December

Form 144 CNB FINANCIAL CORP/PA For: 12 December